Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters

No abstract is available for this paper.

• Publication year

  2013

• Venue

  European Radiology

• Publication date

  2013-06-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00330-013-2902-2PMID 23732688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MRI of the breast in patients with DCIS to exclude the presence of invasive disease

  2012cited by this paper
• Diffusion-weighted imaging of breast masses: comparison of diagnostic performance using various apparent diffusion coefficient parameters.

  2012cited by this paper
• In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters.

  2012cited by this paper
• Diffusion‐weighted MRI as an adjunct to mammography in women under 50 years of age: An initial study

  2012cited by this paper
• Diffusion-weighted imaging of the breast: principles and clinical applications.

  2011cited by this paper
• Characterization of ductal carcinoma in situ on diffusion weighted breast MRI

  2011cited by this paper
• Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.

  2011cited by this paper
• Factors associated with upstaging of ductal carcinoma in situ diagnosed by core needle biopsy using imaging guidance

  2011cited by this paper
• Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors.

  2011cited by this paper
• Apparent diffusion coefficient as an MR imaging biomarker of low-risk ductal carcinoma in situ: a pilot study.

  2011cited by this paper
• Usefulness of diffusion-weighted imaging of breast tumors: quantitative and visual assessment

  2011cited by this paper
• Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size.

  2010cited by this paper
• Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features?

  2010cited by this paper
• Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.

  2010cited by this paper
• Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.

  2010cited by this paper
• Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.

  2010cited by this paper
• The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ

  2010cited by this paper
• Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value.

  2009cited by this paper
• Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method.

  2009cited by this paper
• Comparison of 3.0-and 1.5-tesla diffusion-weighted imaging in the visibility of breast cancer

  2008cited by this paper
• Microinvasive Carcinoma of the Breast

  2008cited by this paper
• The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice.

  2007cited by this paper
• Detecting breast cancer with non-contrast MR imaging: combining diffusion-weighted and STIR imaging.

  2007cited by this paper
• Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade.

  2007cited by this paper
• BI‐RADS MRI Enhancement Characteristics of Ductal Carcinoma In Situ

  2007cited by this paper
• Characteristics of ductal carcinoma in situ in magnetic resonance imaging.

  2007cited by this paper
• Predictors of Residual Invasive Disease after Core Needle Biopsy Diagnosis of Ductal Carcinoma In Situ

  2007cited by this paper
• Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases

  2006cited by this paper
• Predictors of invasion in patients with core‐needle biopsy‐diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ

  2006cited by this paper
• ADC mapping of benign and malignant breast tumors.

  2005cited by this paper
• Ductal carcinoma in situ of the breast.

  2004cited by this paper
• High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement.

  2003cited by this paper
• Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging

  2002cited by this paper
• Ductal carcinoma in situ of the breast.

  2000cited by this paper
• Is the appearance of microcalcifications on mammography useful in predicting histological grade of malignancy in ductal cancer in situ?

  2000cited by this paper
• Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas

  1999cited by this paper
• Consensus conference on the classification of ductal carcinoma in Situ

  1998cited by this paper
• Consensus Conference on the classification of ductal carcinoma in situ. The Consensus Conference Committee.

  1997cited by this paper
• Consensus Conference on the Classification of Ductal Carcinoma In Situ

  1997cited by this paper
• Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions

  1994cited by this paper

• The Role of Apparent Diffusion Coefficient (ADC) in Differentiating Between Benign and Malignant Breast Lesions in a Sample of Iranian Women

  2025influential citation
• Reducing breast biopsy at MRI: comparison of minimum ADC cutoff and mean ADC cutoff identified by the ECOG-ACRIN A6702 multicenter trial

  2025cites this paper
• Prognostic value of diffusion-weighted imaging to cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for patients with gastric cancer and peritoneal metastases

  2025cites this paper
• Breast Diffusion-weighted MR Imaging: Current Applications, Insights from Screening, and Future Directions

  2025cites this paper
• Non-contrast Breast MR Imaging.

  2024cites this paper
• Predictive Performance of Radiomic Features Extracted from Breast MR Imaging in Postoperative Upgrading of Ductal Carcinoma in Situ to Invasive Carcinoma

  2024cites this paper
• Quantitative Assessment of Breast Tumor: Comparison of Four Methods of Positioning Region of Interest for Synthetic Relaxometry and Diffusion Measurement.

  2024cites this paper
• It Is Time to Use Apparent Diffusion Coefficient in Breast MRI Diagnostics.

  2024cites this paper
• Role of combined clinical-radiomics model based on contrast-enhanced MRI in predicting the malignancy of breast non-mass enhancements without an additional diffusion-weighted imaging sequence

  2023cites this paper
• Update on DWI for Breast Cancer Diagnosis and Treatment Monitoring.

  2023cites this paper
• A clinical radiomics nomogram preoperatively to predict ductal carcinoma in situ with microinvasion in women with biopsy-confirmed ductal carcinoma in situ: a preliminary study

  2023cites this paper
• Contrasts Between Diffusion‐Weighted Imaging and Dynamic Contrast‐Enhanced MR in Diagnosing Malignancies of Breast Nonmass Enhancement Lesions Based on Morphologic Assessment

  2023cites this paper
• Breast Magnetic Resonance Imaging Can Predict Ki67 Discordance Between Core Needle Biopsy and Surgical Samples

  2022cites this paper
• Potential of specimen diffusion‐weighted imaging to assess the intraoperative margin for ductal carcinoma in situ and invasive breast cancer

  2022cites this paper
• Diagnostic value of ultrasound elastography in the differentiation of breast invasive ductal carcinoma and ductal carcinoma in situ.

  2022cites this paper
• Diffusion-weighted Breast MRI in Prediction of Upstaging in Women with Biopsy-proven Ductal Carcinoma in Situ.

  2022cites this paper
• Apparent diffusion coefficient and intravoxel incoherent motion-diffusion kurtosis model parameters in invasive breast cancer: Correlation with the histological parameters of whole-slide imaging.

  2022cites this paper
• Non-Mass Enhancements on DCE-MRI: Development and Validation of a Radiomics-Based Signature for Breast Cancer Diagnoses

  2021cites this paper
• Diffusion-weighted imaging of breast invasive lobular carcinoma: comparison with invasive carcinoma of no special type using a histogram analysis.

  2021cites this paper
• Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging

  2021cites this paper
• Assessment of histologic prognostic factors of resectable rectal cancer: comparison of diagnostic performance using various apparent diffusion coefficient parameters

  2020cites this paper
• Effective apparent diffusion coefficient parameters for differentiation between mass-forming autoimmune pancreatitis and pancreatic ductal adenocarcinoma

  2020cites this paper
• The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situ

  2020cites this paper
• Turbo Spin-echo Diffusion-weighted Imaging Compared with Single-shot Echo-planar Diffusion-weighted Imaging: Image Quality and Diagnostic Performance When Differentiating between Ductal Carcinoma in situ and Invasive Ductal Carcinoma

  2020cites this paper
• Magnetic resonance imaging of the breast: role in the evaluation of ductal carcinoma in situ

  2019cites this paper
• Diffusion-weighted Imaging of Invasive Breast Cancer: Relationship to Distant Metastasis-free Survival.

  2019cites this paper
• Diffusion-weighted imaging of the breast: current status as an imaging biomarker and future role

  2019cites this paper
• Predicting metastasis in clinically negative axillary lymph nodes with minimum apparent diffusion coefficient value in luminal A-like breast cancer

  2019cites this paper
• Quantitative analysis of diffusion-weighted imaging in high-risk patients and newly diagnosed breast cancer patients; a systematic review

  2019cites this paper
• Characterization of Breast Lesions Using Diffusion Kurtosis Model-Based Imaging

  2019cites this paper
• Can apparent diffusion coefficient (ADC) distinguish breast cancer from benign breast findings? A meta-analysis based on 13 847 lesions

  2019cites this paper
• Role of Breast MRI in the Evaluation and Detection of DCIS: Opportunities and Challenges.

  2019cites this paper
• Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy

  2019cites this paper
• Characterization of breast lesions using diffusion kurtosis model-based imaging: An initial experience

  2019cites this paper
• Clinical Predictors of Upstaging to Invasive Cancer Postoperatively in Patients Diagnosed with Ductal Carcinoma In Situ before Surgery

  2019cites this paper
• Correlation between minimum apparent diffusion coefficient values and the histological grade of breast invasive ductal carcinoma.

  2018cites this paper
• Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI

  2018cites this paper
• Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?

  2017cites this paper
• Utility of apparent diffusion coefficient as an imaging biomarker for assessing the proliferative potential of invasive ductal breast cancer.

  2017cites this paper
• Fast bilateral breast coverage with high spectral and spatial resolution (HiSS) MRI at 3T

  2017cites this paper
• Intratumoural heterogeneity measured using FDG PET and MRI is associated with tumour-stroma ratio and clinical outcome in head and neck squamous cell carcinoma.

  2017cites this paper
• DWI in the Assessment of Breast Lesions

  2017cites this paper
• Diffusion‐weighted breast MRI: Clinical applications and emerging techniques

  2017cites this paper
• Diffusion-weighted imaging of breast lesions: Region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values

  2017cites this paper
• MRI and Preoperative Staging in Women Newly Diagnosed with Breast Cancer

  2017cites this paper
• Histogram analysis of volume-based apparent diffusion coefficient in breast cancer

  2017cites this paper
• Characterization of breast masses as benign or malignant at 3.0T MRI with whole‐lesion histogram analysis of the apparent diffusion coefficient

  2016cites this paper
• Improving the Accuracy of Computer-aided Diagnosis for Breast MR Imaging by Differentiating between Mass and Nonmass Lesions.

  2016cites this paper
• Peritumoral apparent diffusion coefficients for prediction of lymphovascular invasion in clinically node-negative invasive breast cancer

  2016cites this paper
• Differences in morphological features and minimum apparent diffusion coefficient values among breast cancer subtypes using 3-tesla MRI.

  2016cites this paper
• Semi‐automated quantitative intravoxel incoherent motion analysis and its implementation in breast diffusion‐weighted imaging

  2016cites this paper
• improving the accuracy of computer-aided Diagnosis for Breast M r imaging by Differentiating between Mass

  2016cites this paper
• Clinical Breast MR Using MRS or DWI: Who Is the Winner?

  2016cites this paper
• Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.

  2016cites this paper
• Computer assisted detection and characterisation of breast cancer in MRI

  2015cites this paper
• Correlation of Apparent Diffusion Coefficients with the Ki-67 Labeling

  2015cites this paper
• Utility of diffusion tensor imaging in predicting pathological T-factor in breast cancer showing nonmasslike-enhancement on breast MRI

  2015influential citation
• Simple magnetic resonance imaging criteria can differentiate ductal carcinomas in situ from invasive carcinomas

  2015cites this paper
• Correlations between apparent diffusion coefficient values of invasive ductal carcinoma and pathologic factors on diffusion‐weighted MRI at 3.0 Tesla

  2015cites this paper
• Emerging Technologies in Breast Imaging

  2015cites this paper
• Correlation between 3T apparent diffusion coefficient values and grading of invasive breast carcinoma: Cipolla V, Santucci D, Guerrieri D, et al (Univ of Rome “Sapienza”, Italy) Eur J Radiol 83:2144-2150, 2014§

  2015cites this paper
• Quantitative Apparent Diffusion Coefficient as a Noninvasive Imaging Biomarker for the Differentiation of Invasive Breast Cancer and Ductal Carcinoma In Situ

  2015cites this paper
• Intratumoral metabolic heterogeneity predicts invasive components in breast ductal carcinoma in situ

  2015cites this paper
• Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index.

  2015cites this paper
• Diffusion-weighted magnetic resonance imaging of breast lesions: the influence of different fat-suppression techniques on quantitative measurements and their reproducibility

  2014cites this paper